Anonymous
Guest
Anonymous
Guest
The good news: revenues for pharma globally are increasing at between 7.7% - 10.4% per year (adjusting for inflation), and profits % is up by 13.2% in the 5 year period ended 31-Dec-2013.
The downside: US-based pharma/device/biotech payrolls have been steadily decreasing at 2.7% per year over the last ten years.
Bottom Line: Higher paying American-based jobs are being cut, while lower paying Asian-based jobs are increasing: for example, NVS is moving 5000 jobs to India over the next 18 months at 70% less pay (salary is still higher by Indian standards)
Horror story: Lower quality products, fake clinical trials, and bribery-driven sales are all set to increase exponentially - India is corrupt to the core
This isn't true in Switzerland. They've Obamacare for years, have a higher per capita GDP, have unions throughout out the country yet are ranked as a more competitive economy than ours - thanks GOP!